Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
physostigmine
physostigmine
- Formulary
VIEW MORE Parasympathomimetic (Cholinergic) Agents
Last updated: May. 13, 2026
Physostigmine is no longer commercially available as 2 mg/2 mL. (Updated April 2023)
Temporary importation of 2 mg/5 mL product approved by FDA. (Updated November 2023)
Shortage Strategy (supply exhausted as of May 2026):
In the event that physostigmine is unavailable, consider use of rivastigmine orally/enterally [see anticholinergic toxicity for dosing strategies] in addition to supportive care.